Author:
Hernández-Gea Virginia,Turon Fanny,García-Pagán Juan Carlos
Reference30 articles.
1. Gulberg V, Deibert P, Ochs A, Rossle M, Gerbes AL. Prevention of infectious complications after transjugular intrahepatic portosystemic shunt in cirrhotic patients with a single dose of ceftriaxone. Hepatogastroenterology. 1999;46:1126–30.
2. Debernardi-Venon W, Bandi JC, Garcia-Pagan JC, Moitinho E, Andreu V, Real M, et al. CO(2) wedged hepatic venography in the evaluation of portal hypertension. Gut. 2000;46:856–60.
3. Reverter E, Blasi A, Abraldes JG, Martinez-Palli G, Seijo S, Turon F et al. Impact of deep sedation on the accuracy of hepatic and portal venous pressure measurements in patients with cirrhosis. Liver Int. 2013. doi:
10.1111/liv.12229
. [Epub ahead of print]
4. Bureau C, Pagan JC, Pomier-Layrargues G, Metivier S, Bellot P, Perreault P, et al. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Liver Int. 2007;27:742–7.
5. Bureau C, Garcia-Pagan JC, Otal P, Pomier-Layrargues G, Chabbert V, Cortez C, et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology. 2004;126:469–75.